Pyruvate dehydrogenase can be phosphorylated by ATP to yield an inactive phosphoenzyme, which can be reactivated through the action of a calcium-dependent phosphatase (Linn et al., 1969; Severson et al., 1974). We have measured the fraction of enzyme in the active form in a series of rat hearts frozen at various time-intervals after a sudden increase in cardiac output.
Pyruvate dehydrogenase can be phosphorylated by ATP to yield an inactive phosphoenzyme, which can be reactivated through the action of a calcium-dependent phosphatase (Linn et al., 1969; Severson et al., 1974) . We have measured the fraction of enzyme in the active form in a series of rat hearts frozen at various time-intervals after a sudden increase in cardiac output.
Sprague-Dawley rat hearts were perfused at 35°C with Krebs bicarbonate Ringer containing 1 mwpyruvate, by using the closed-aorta technique (Illingworth & Mullings, 1976) . After a 15min equilibration period at low cardiac output (aortic pressure 45mmHg, coronary flow rate 4.64ml/min per g wet wt.), the hearts were subjected to a sudden increase in left-atrial filling pressure sufficient to produce the maximum possible cardiac work output. Stroke volume, aortic pressure and coronary flow rate increased within 4s to three times their resting values. O2 uptake, C 0 2 production and substrate uptake increased more slowly, so that a new steady state was not established until 60s after the work increase.
Frozen heart samples were powdered in liquid N2, and lOOmg of heart powder was homogenized at 0°C with 2ml of 50m~-potassium phosphate buffer, pH7.5, containing 5mM-EDTA and 1 mM-dithiothreitol. The homogenate was divided into two samples. One was assayed at once for active (dephospho-) pyruvate dehydrogenase (Illingworth 8c Mullings, 1976) , and the other was incubated at room temperature for 30min with 5 m~-C a C l~ + 7.5m~-MgCI, before assay in order to convert the enzyme entirely into the active form.
The results are summarized in Table 1 . The data for pyruvate oxidation rate represent myocardial pyruvate-uptake rate minus the rate of lactate production. The total pyruvate dehydrogenase assayed after activation with CaCI,+MgCI, in vitro did not change significantly with time after the work jump. The mean value was 45.43+ 1.16nrnol/min per mg of protein. It is clear that a close correlation exists between the active pyruvate dehydrogenase fraction assayed in vitro and the uptake of pyruvate by the perfused heart. Reaction rates were slightly higher in vitro, as might be expected since saturating concentrations ofsubstrate wereadded to the homogenate, and theenzyme was probably (Illingworth et al., 1975) . This suggests that citrate synthase activity is limited by acetyl-CoA availability under these circumstances, and shows that pyruvate dehydrogenase can exercise effective control over citric acidcycle flux during a work transition. These earlier experiments also showed that increased cardiac output led to a fall in the mitochondrial NADH/NAD+ and ATP/ADP ratios, and resulted in a decline in myocardial citrate content and an increase in the PI concentration. An elevated mitochondrial calcium content might also be expected under the same conditions. All these changes should lead to an activation of pyruvate dehydrogenase (Taylor & Halperin, 1973; Chiang & Saktor, 1975; Cooper et al., 1975) and at present it is difficult to identify the dominant effectors. However, we suspect that the high tissue citrate content (4.5,umol/g dry wt. in the low-output state) provides a valuable counterbalance to the activating effect of pyruvate, and allows the other control systems to operate correctly. The hepatotoxicity of paracetamol has similarities to that of carbon tetrachloride. Antioxidants modify carbon tetrachloride toxicity, and some evidence suggests that this protection is mediated by their action as free-radical scavengers and prevention of lipid peroxidation (Recknagel, 1967) . We have previously shown that vitamin E, when administered either before or after large doses of paracetamol in the rat, decreases the hepatotoxicity (Walker et al., 1974) . To clarify further the mechanism of this protection and to assess the importance of peroxidative damage, we have studied the effects of two other antioxidants, NN-diphenyl-p-phenylenediamine and propylgallate, against paracetamol hepatotoxicity.
Starved male Wistar rats (200420%) were used. Groups of eight were treated with either 600mg of NN-diphenyl-p-phenylenediamine or 300mg of propylgallate/kg body weight, 72, 48, 24 and 6 h before paracetamol treatment. Each antioxidant was administered orally by stomach tube as an aqueous suspension stabilized with0.2 % tragacanth.
Control groups of eight rats were pretreated at the same times with an equal volume of 0.2 % tragacanth. At 6h after the last oral dose, paracetamol was administered orally as a suspension (1.28 mol/litre) stabilized with 0.2 % tragacanth. Toxicity was assessed from mortality by 24 and 48h after the paracetamol treatment and/or plasma activities of aspartate aminotransferase (EC 2.6.1.1) at 24h in surviving animals.
